Table 1.

Clinical information of the patient with myocarditis after BNT162b2 vaccination

Day	Test		Result	Reference
10	NT-proBNP (pg/ml)		1,113.00	5-125
	CK-MB (ng/ml)		22.70	0.3-4.94
	Troponin-T (ng/ml)		0.019	<0.099
	C-reactive protein (mg/dl)		0.18	<0.5
	ECG		PVC
			T-wave inversion at V5-6
			ST-segment elevation at V1-4
15	Transthoracic echocardiography	Diastolic left ventricular internal diameter (mm)	62
		Left ventricular ejection fraction (%)	24
16	Coronary angiography		Normal
	Endocardial biopsy		A few microfoci of myofiber eosinophilic changes
			Disrupted myocytes
			Inflammatory infiltrates showing mild extent and focal distribution
			Lymphocytic type without fibrosis
	CK-MB (ng/ml)		13.2	0.3-4.94
17	Cardiac magnetic resonance imaging		Myocardial edema on T2-weighted study
			Late gadolinium enhancement at basal to mid antero-septal wall of LV
	CK-MB (ng/ml)		6.69	0.3-4.94
18	CK-MB (ng/ml)		3.86	0.3-4.94
20	CK-MB (ng/ml)		10.60	0.3-4.94
	ECG		T-wave inversion at V5-6
			ST-segment elevation at V1-4
24	C-reactive protein (mg/dl)		1.02	<0.5